Pharma News

The duo explained that the AI model’s natural language processing allowed them to pick up subtleties and changes in speech that they may have otherwise been missed.

New Delhi.

Dr.

AstraZeneca is divesting two cardiovascular drugs to Germany’s Cheplapharm Arzneimittel GmbH for $400 million, which will allow the UK pharma giant to reinvest in its main therapy areas.

GENEVA (Reuters) - A group of World Health Organization (WHO) experts held a virtual meeting with Chinese counterparts on Friday to discuss the coronavirus pandemic, WHO chief Tedros A...

Bristol Myers Squibb has signed a five-year collaboration agreement with machine learning specialist insitro to develop drugs for amyotrophic lateral sclerosis (ALS) and frontotemporal dementi...

Sanofi is partnering with Merck to test its THOR-707 compound with Merck’s checkpoint inhibitor Keytruda (pembrolizumab) in solid tumors.

Gilead Sciences reported stronger-than-expected third-quarter earnings on Wednesday as sales of its coronavirus treatment remdesivir touted by President Donald Trump drove revenue up by 17% from l...

The agreement with Eli Lilly is for delivery over the two months following an emergency use authorization from the Food and Drug Administration.

AstraZeneca’s Enhertu has scored a priority review from the US Food and Drug Administration (FDA) for the treatment of HER2-positive metastatic gastric cancer.

Sanofi and Regeneron's immunology superstar Dupixent is well on its way to world domination with a flood of new indications in the pipeline.

LONDON (Reuters) - One of the world’s leading COVID-19 experimental vaccines produces an immune response in both young and old adults, raising hopes of a path out of the gloom and economic d...